Navigation Links
Chemo During Pregnancy Doesn't Seem to Harm Newborn
Date:8/15/2012

WEDNESDAY, Aug. 15 (HealthDay News) -- Women who need chemotherapy for breast cancer during pregnancy should not compromise their treatment or deliver their babies early, a new study says.

In the study, published online Aug. 15 in The Lancet Oncology, researchers in Germany found that babies born to breast cancer patients who had chemotherapy while they were pregnant were not at greater risk for complications. They also found that the babies who did suffer from complications were premature, regardless of whether or not they were exposed to chemotherapy.

"Our findings emphasize the importance of prioritizing a full-term delivery in women who undergo chemotherapy while pregnant," study leader Sibylle Loibl, of the German Breast Group, said in a journal news release.

"Illness and mortality in newborn babies is directly related to gestational age at delivery," Loibl stressed. "This is an important clinical message because the decision to deliver the fetus preterm is often taken without medical indication. Our work suggests that treating patients with breast cancer while pregnant is possible, and there is no need to interrupt the pregnancy or receive inferior therapy."

In conducting the study, the researchers examined more than 400 European women diagnosed with early stage breast cancer while they were pregnant. Of these women, 48 percent underwent chemotherapy during their pregnancy.

The infants exposed to chemotherapy in the womb had, on average, a lower birth weight than other infants who were not exposed to the cancer drugs, the study found. The authors pointed out, however, that that was about the only noticeable difference among the babies, and the number of chemotherapy cycles the women received did not appear to affect their babies' birth weight.

Complications among the infants were more often associated with preterm delivery, regardless of exposure to chemotherapy in the womb, the researchers noted. Half of the women in the study delivered prematurely. Of these, 23 percent gave birth before they were 35 weeks pregnant. In comparison, about 10 percent to 15 percent of infants are born preterm in the general population, Loibl pointed out in the news release.

"If our findings are confirmed by other studies, breast cancer during pregnancy could be treated as it is in nonpregnant women without putting fetal and maternal outcomes at substantially increased risk," Loibl concluded.

In response to the study's findings, Dr. Olivier Mir, of the Cancer Associated with Pregnancy Network in France, said more research is needed to determine the best chemotherapy doses for pregnant women as well as the long-term risks children face from having been exposed to the cancer drugs in the womb.

More information

The U.S. National Library of Medicine has more about chemotherapy.

-- Mary Elizabeth Dallas

SOURCE: The Lancet Oncology, news release, Aug. 15, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
3. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
4. Chemo + Radiation Best for Bladder Cancer, Study Finds
5. Genetic predictor of breast cancer response to chemotherapy
6. Chemotherapys effect on overall survival seems to increase based on tumor size
7. Many Primary Care Docs Dont Know Long-Term Effects of Chemo: Survey
8. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
9. Study: Heart damage after chemo linked to stress in cardiac cells
10. Breast MRI helps predict chemotherapys effectiveness
11. Why chemotherapy fails
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo During Pregnancy Doesn't Seem to Harm Newborn
(Date:2/8/2016)... Washington, D.C. (PRWEB) , ... February 08, 2016 ... ... has officially launched its newly redesigned website, federallabs.org . The site houses ... technologies or license available federal technologies through the process called technology transfer (T2). ...
(Date:2/8/2016)... Houma, LA (PRWEB) , ... February 08, 2016 ... ... Louisiana from offices in Houma, LA, celebrates the beginning of a new charity ... raised to assist Court Appointed Special Advocates (CASA). In the belief that children ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , ... bags, and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. ... up to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly ...
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance ... new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse in ... intimate abuse. To support all those victimized by the fear of violence in their ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California and its affiliated ... , Gary D. Radine, who recently retired as president and CEO of Delta Dental ... 2015 CEO of the Year , helped lead the effort to raise funds for ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... Feb. 8, 2016 Palatin Technologies, Inc. ... receptor-specific peptide therapeutics for the treatment of diseases ... announced today that the United States Patent and ... Allowance for U.S. Patent Application Serial Number 14/313,258 ... methods of treating female sexual dysfunction using the ...
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: AMGN ... Annual Global Healthcare Conference at 9:15 a.m. ET on Wednesday, ... . David W. Meline , executive vice president and ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology: